Literature DB >> 16110613

Epidermal growth factor receptor pathway inhibitors.

Jose Baselga1, Javier Cortes.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16110613     DOI: 10.1016/s0921-4410(04)22009-9

Source DB:  PubMed          Journal:  Cancer Chemother Biol Response Modif        ISSN: 0921-4410


× No keyword cloud information.
  5 in total

1.  Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R.

Authors:  Kerrington R Molhoek; Amber L Shada; Mark Smolkin; Sudhir Chowbina; Jason Papin; David L Brautigan; Craig L Slingluff
Journal:  Melanoma Res       Date:  2011-08       Impact factor: 3.599

2.  Receptor-based virtual screening of EGFR kinase inhibitors from the NCI diversity database.

Authors:  Kiattawee Choowongkomon; Orathai Sawatdichaikul; Napat Songtawee; Jumras Limtrakul
Journal:  Molecules       Date:  2010-06-04       Impact factor: 4.411

3.  Isolation and identification of three new chromones from the leaves of Pimenta dioica with cytotoxic, oestrogenic and anti-oestrogenic effects.

Authors:  Brian J Doyle; Temitope O Lawal; Tracie D Locklear; Lorraina Hernandez; Alice L Perez; Udeshi Patel; Shitalben Patel; Gail B Mahady
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

4.  The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells.

Authors:  Hong-Qing Zhuang; Jun-Jie Wang; An-Yan Liao; Ji-Dong Wang; Yong Zhao
Journal:  J Exp Clin Cancer Res       Date:  2009-01-29

5.  Research progress on criteria for discontinuation of EGFR inhibitor therapy.

Authors:  Hong-Qing Zhuang; Zhi-Yong Yuan; Jun Wang; Ping Wang; Lu-Jun Zhao; Bai-Lin Zhang
Journal:  Onco Targets Ther       Date:  2012-10-15       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.